Thirty-five Bacteroides fragilis clinical isolates with varying susceptibility to meropenem were analysed with a prototype of a double-ended Etest strip containing meropenem ± EDTA, designed for the detection of the CfiA metallo-β-lactamase. Phenotypic results obtained with this new Etest strip were related to the genotype and compared to the results of the Etest containing imipenem ± EDTA. Whereas the Etest with imipenem ± EDTA only allowed detection of isolates with high-level resistance (both MICs of imipenem and meropenem >32 mg/L), reflecting the possible underestimation of CfiA prevalence in B. fragilis, the Etest with meropenem ± EDTA proved to be more accurate, particularly for isolates with low-level carbapenem resistance, suggesting its potential for broader detection of CfiA production. © 2008 The Authors Journal compilation © 2008 European Society of Clinical Microbiology and Infectious Diseases.
CITATION STYLE
Bogaerts, P., Engelhardt, A., Berhin, C., Bylund, L., Ho, P., Yusof, A., & Glupczynski, Y. (2008). Evaluation of a new meropenem-EDTA double-ended Etest strip for the detection of the cfiA metallo-β-lactamase gene in clinical isolates of Bacteroides fragilis. Clinical Microbiology and Infection, 14(10), 973–977. https://doi.org/10.1111/j.1469-0691.2008.02065.x
Mendeley helps you to discover research relevant for your work.